January 2025
The asthma drugs market was valued at USD 25.17 billion in 2024 and is expected to hit around USD 41.04 billion by 2034, growing at a CAGR of 5.01% from 2025 to 2034.
March 2025
The U.S. over the counter (OTC) drugs market size was estimated at USD 23.84 billion in 2024 and is predicted to increase from USD 24.81 billion in 2025 to approximately USD 44.17 billion by 2034, expanding at a CAGR of 6.60% from 2025 to 2034.
March 2025
The global PD-1 inhibitor drugs market size was estimated at USD 42.11 billion in 2024 and is expected to hit around USD 179.77 billion by 2034, growing at a CAGR of 15.62% from 2025 to 2034.
March 2025
The global generic drugs market size was calculated at USD 445.62 billion in 2024 and is predicted to increase from USD 468.08 billion in 2025 to approximately USD 728.64 billion by 2034, expanding at a CAGR of 5.04% from 2025 to 2034.
September 2024
The global market size is predicted to increase from USD 36.22 billion in 2024 to approximately USD 66.16 billion by 2034, expanding at a CAGR of 6.21%.
September 2024
The global atrial fibrillation drugs market size is estimated to surpass around USD 20.99 billion by 2034 from USD 15.59 billion in 2024, with a CAGR of 3.02%.
August 2024
The oncology/cancer drugs market size is calculated at USD 172.39 billion in 2024 and is projected to hit around USD 507.68 billion by 2034 with a CAGR of 11.41%.
March 2025
The global over the counter (OTC) drugs market size was valued at USD 129.80 billion in 2024 and is expected to hit around USD 242.94 billion by 2034, growing at a CAGR of 6.72% from 2025 to 2034.
April 2025
The global immunotherapy drugs market size reached USD 270.2 billion in 2024 and is projected to surpass around USD 1,414.16 billion by 2034, with a solid CAGR of 18%.
April 2025
The global head and neck cancer drugs market size reached USD 1.90 billion in 2024 and is projected to hit around USD 4.06 billion by 2034 with a CAGR of 7.88%.
January 2025
The global asthma and COPD drugs market size was estimated at USD 40.3 billion in 2024 and is expected to hit USD 86.36 billion by 2034, growing at a CAGR of 7.92%.
January 2025
The global contraceptive drugs market size was valued at USD 17.94 billion in 2024 and is expected to hit around USD 31.60 billion by 2034, at a CAGR of 5.82%.
June 2024
The global rheumatoid arthritis drugs market size was valued at USD 63.22 billion in 2024 and is expected to hit around USD 75.53 billion by 2034, growing at a CAGR of 1.80% from 2025 to 2034.
March 2025
The global cardiovascular drugs market size was calculated at USD 149.99 billion in 2024 and is predicted to increase from USD 155.96 billion in 2025 to approximately USD 214.72 billion by 2034, expanding at a CAGR of 3.62% from 2025 to 2034.
February 2025
The global antipsychotic drugs market size was estimated at USD 18.49 billion in 2024 and is predicted to increase from USD 19.61 billion in 2025 to approximately USD 33.09 billion by 2034, expanding at a CAGR of 5.99% from 2025 to 2034.
December 2024
The global orphan drugs market size is estimated at USD 193.01 billion in 2024 and is anticipated to reach around USD 610.24 billion by 2034, expanding at a CAGR of 12.20% from 2024 to 2034.
December 2024
The global dermatology drugs market size was calculated at USD 21.43 billion in 2024 and is projected to hit around USD 62.63 billion by 2034 with a CAGR of 11.32% .
September 2024
The global anti-obesity drugs market size is estimated to hit around USD 55.25 billion by 2034 increasing from USD 5.69 billion in 2024, with a CAGR of 5.53%.
August 2024
The global veterinary dermatology drugs market size is calculated at USD 8.20 billion in 2024 and is projected to hit around USD 19.28 billion by 2034 with a CAGR of 8.93%.
January 2025
The global ophthalmic drugs market size accounted for USD 43.19 billion in 2024 and is expected to exceed USD 72.38 billion by 2034, growing at a CAGR of 5.30% from 2025 to 2034.
April 2025
The U.S. generic drugs market size was estimated at USD 139.03 billion in 2024 and is predicted to increase from USD 146.04 billion in 2025 to approximately USD 231.69 billion by 2034, expanding at a CAGR of 5.24% from 2025 to 2034.
March 2025
The global pain management drugs market size was calculated at USD 84.08 billion in 2024 and is predicted to increase from USD 87.19 billion in 2025 to approximately USD 125.68 billion by 2034, expanding at a CAGR of 4.10% from 2025 to 2034.
July 2024
The global intravenous iron drugs market size accounted for USD 3.53 billion in 2023 and is predicted to hit around USD 8.19 billion by 2034 at a CAGR of 8.8%.
November 2024
The global nephrology drugs market size is estimated at USD 17.71 billion in 2024 and is anticipated to reach around USD 30.30 billion by 2034, expanding at a CAGR of 5.52% from 2024 to 2034.
December 2024
The global antifungal drugs market size was calculated at USD 17.39 billion in 2024 and is projected to surpass around USD 24.51 billion by 2034, growing at a CAGR of 3.49% from 2025 to 2034.
September 2024
The global cancer supportive care drugs market size is projected to hit around USD 26.90 billion by 2034 from USD 21.85 billion in 2024 with a CAGR of 2.1%.
July 2024
The omega 3 prescription drugs market size accounted for USD 1.44 billion in 2024 and is predicted to hit around USD 2.93 billion by 2034 with a CAGR of 7.37%.
November 2024
The global general anesthesia drugs market size was valued at USD 5.40 billion in 2024 and is expected to hit around USD 7.79 billion by 2034, with a CAGR of 3.72%.
July 2024
The atopic dermatitis drugs market size is calculated at USD 14.72 billion in 2022 and is projected to hit around USD 27.33 billion by 2032 with a CAGR of 8.1%.
October 2024
The global hyperlipidemia drugs market size is expected to be valued at USD 22.93 billion in 2024 and is anticipated to reach around USD 33.94 billion by 2034, expanding at a CAGR of 4% over the forecast period from 2024 to 2034.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com